What to Do After IVF Failure in Hong Kong: Cause Analysis & Next Treatment Plan Guide
After IVF failure in Hong Kong, systematically analyze causes including embryo factors, endometrial receptivity, and immune factors. Develop an individualized next-step plan based on failure type, involving embryo genetic testing, hysteroscopy, and endometrial preparation protocol adjustments. It is recommended to discuss the reasons for failure in detail with your primary doctor before deciding on next steps.
After IVF Failure, First Identify Which Stage the Failure Occurred
43 years old, AMH 0.8, completed first IVF at a fertility center in Hong Kong. 4 eggs retrieved, 3 mature, 2 fertilized, only one 6-cell embryo by day 3, HCG blood test on day 12 post-transfer showed no implantation. This is a typical consultation in the clinic. The core of what to do after IVF failure in Hong Kong lies in answering a more fundamental question first: At which specific stage did the failure occur?
IVF failure is not a single event but includes at least the following six possibilities:
- Egg Retrieval Failure: Number of eggs retrieved is far lower than expected, or no eggs are retrieved.
- Fertilization Failure: Egg and sperm do not combine, or fertilization rate is low.
- Embryo Developmental Arrest: The fertilized egg stops dividing on day 3 or day 5-6.
- No Transferable Embryo: All embryos fail to meet transfer criteria.
- No Implantation After Transfer: No HCG detected after embryo transfer.
- Biochemical Pregnancy or Early Miscarriage: HCG positive but subsequently declines, or no gestational sac seen on ultrasound.
Failure at different stages points to different causes and next steps. Entering the next cycle without differentiation may repeat the same outcome.
Why Analyze Failure Causes by Stage
Each failure stage points to different potential issues:
| Failure Stage | Common Cause Direction |
|---|---|
| Egg Retrieval Failure / Low Egg Yield | Diminished ovarian reserve (low AMH, low antral follicle count), poor response to stimulation protocol, trigger timing or dosage issues |
| Fertilization Failure or Low Fertilization Rate | Sperm quality (DNA fragmentation, morphology), egg maturity, ICSI procedure related |
| Embryo Developmental Arrest | Embryo chromosomal abnormalities (especially advanced maternal age), sperm/egg genomic quality, culture conditions |
| No Transferable Embryo | Same as above, or all abnormal after PGT screening |
| No Implantation After Transfer | Endometrial receptivity (thickness, pattern, ERA), immune factors, embryo chromosomal abnormalities, endometritis |
| Biochemical Pregnancy / Early Miscarriage | Embryo chromosomal abnormalities, endocrine factors, thyroid function, autoimmune antibodies, coagulation function |
The above classification is not absolute but helps doctors narrow down the investigation. It is recommended that patients request a clear cycle summary from their doctor after the cycle ends, noting the level of possible causes for failure (highly suspected / possible / to be ruled out).
Most Easily Overlooked Details: Male Factor and Endometrial Microenvironment
In Hong Kong clinical practice, two areas are often underestimated:
Male Sperm DNA Fragmentation Index
A normal routine semen analysis does not guarantee a normal DNA fragmentation index. When the fragmentation rate exceeds 30%, even if fertilization is successful, the embryo is prone to arrest after day 3 or form a low-quality blastocyst. When to check: female age ≤35 but poor embryo quality, history of miscarriage, or male with smoking/varicocele history. It is recommended to complete sperm DNA fragmentation testing before the next cycle. Laboratories can improve outcomes through sperm selection or using testicular sperm.
Chronic Endometritis
Among patients with recurrent implantation failure, about 30%-40% have chronic endometritis, which may appear completely normal on routine ultrasound or hysteroscopy. Diagnosis requires CD138 immunohistochemical staining. When is it suitable: ≥2 transfers of good quality embryos without implantation, or history of uterine procedures. After antibiotic treatment, implantation rates can significantly improve.
Different Age Groups Require Different Priorities
For IVF failure in Hong Kong, the analysis logic differs greatly between those under 35 and those over 42.
| Age Group | Priority Investigation Direction | Next Step Testing Suggestions |
|---|---|---|
| ≤35 years | Uterine factors, immune factors, sperm DNA fragmentation, stimulation protocol | Hysteroscopy + ERA + sperm DFI + thyroid antibodies |
| 36-39 years | Embryo chromosomal aneuploidy, ovarian response, endometrial receptivity | PGT-A + AMH/antral follicle assessment + ERA |
| ≥40 years | Significantly increased embryo chromosomal abnormality rate, diminished ovarian reserve | Egg/embryo donation evaluation, PGT-A, mitochondrial DNA testing (research) |
For patients ≥42 years, the probability of a chromosomally normal embryo per cycle is usually less than 15%. PGT-A can help with selection, but patients should be informed that failure may still occur due to embryo mosaicism or technical limitations.
How Doctors View "Changing Hospitals After Failure"
Changing hospitals is a decision that requires careful consideration. When is it suitable to change: the original center did not provide an individualized stimulation protocol, lab quality control is not transparent, or the doctor did not perform a systematic analysis of the failure cause. When is it not suitable: changing solely due to one failure, or expecting a completely different success rate at the new center.
There are indeed differences in lab levels, culture systems, and PGT technology platforms among different fertility centers in Hong Kong. However, the key is whether the new doctor can obtain complete cycle records, including: stimulation drug dosage and response curve, embryo photos or grading, and transfer procedure records. It is recommended to consult at least one reproductive doctor outside the original center with all records to get a second opinion before deciding.
Specific process: Request copies of all medical records (including nursing and lab records) from the original center, then schedule an initial consultation at the new center. In Hong Kong, the statutory medical record retention period is at least 7 years, and patients have the right to obtain copies.
Five Most Common Pitfalls
- Ignoring Mental State: After one failure, anxiety and stress can directly affect endocrine function and endometrial receptivity. It is recommended to rest for 2-3 natural cycles to allow physical and psychological recovery.
- Blindly Taking Supplements: DHEA, Coenzyme Q10, Melatonin are effective for specific groups but not for everyone. For example, DHEA is only suitable for those with low ovarian reserve and low DHEA-S levels; misuse can lead to high androgen levels.
- Giving Up Too Early: One failure does not predict the next outcome. Statistically, for patients under 40, the cumulative live birth rate over 3 consecutive cycles can reach 60%-70% (depending on the specific diagnosis).
- Excessive Testing: Not everyone who fails needs a full immune panel, ERA, or reproductive tract microbiome testing. It is recommended to selectively test based on the type of failure under a doctor's guidance to avoid financial burden and issues from false positives.
- Neglecting Basic Health Status: BMI >28 or <18, uncontrolled thyroid disease, vitamin D deficiency, sleep disorders—all these can affect pregnancy outcomes. It is advisable to adjust these to a reasonable range before starting the next cycle.
Frequently Asked Questions Summary
Q1: How long should I wait after IVF failure in Hong Kong before trying again?
Medically, it is recommended to wait for 2-3 normal menstrual cycles. For patients who had a fresh transfer, the ovaries need time to recover. For frozen embryo cycles, if no stimulation drugs were used, one menstrual cycle may be sufficient. However, the more important factor is whether necessary tests and analyses have been completed. If tests take 1-2 months, natural cycle recovery and testing can proceed simultaneously.
Q2: Do I need a hysteroscopy after failure?
Not everyone needs it. When is it suitable: recurrent implantation failure (≥2 transfers of good quality embryos without implantation), ultrasound suggesting abnormal endometrial echo, history of intrauterine adhesions or polyps, history of miscarriage or D&C. When is it not needed: first transfer failure, normal endometrial pattern, no relevant history. Hysteroscopy is the gold standard for diagnosing uterine abnormalities but is an invasive procedure, requiring a balance of benefits.
Q3: After IVF failure in Hong Kong, is it recommended to go to mainland China or other countries?
This depends on the specific reason for failure. If the core issue is extremely low ovarian reserve or severe sperm quality abnormalities, changing location will not solve the biological problem. If there is a need for higher-level lab technology (e.g., PGT-M, time-lapse culture, mitochondrial replacement), a referral could be considered. Hong Kong's regulatory framework differs from mainland China, with stricter indications for PGT, but overall lab quality control standards are high. It is recommended to ask the center about their blastocyst formation rate, post-PGT biopsy survival rate, and freeze-thaw survival rate.
Q4: Do I need a full immune panel after failure?
There is currently no unified consensus. Immune-related pregnancy failures with clear evidence include: antiphospholipid syndrome, systemic lupus erythematosus, abnormally elevated NK cells (research). When is screening recommended: ≥2 failed transfers after excluding embryo and uterine factors, history of autoimmune disease, history of thrombosis. It is not recommended to do dozens of immune tests after the first failure, as the false positive rate is high and may lead to unnecessary medication.
Practitioner Observation: Learning from Failure Records
In practice, a common phenomenon is that patients oversimplify their understanding of the failure cause. For example, thinking "poor embryo quality" explains everything, but digging deeper: was it poor morphological grading or chromosomal abnormality? Was it egg-derived or sperm-derived? Was it caused by the stimulation protocol or the lab culture process?
A good fertility center will provide a cycle review record after the cycle ends, including: number of eggs retrieved vs. expected, fertilization method and rate, embryo development timeline, post-transfer HCG curve, and the doctor's analysis level of the failure cause. If the center does not proactively provide it, patients are advised to request it.
Another observation is that some patients, after IVF failure in Hong Kong, immediately consider switching to "PGT-A." But PGT-A cannot solve all problems, especially when the number of embryos is very small. For those with AMH <1.0, the rate of usable embryos after PGT-A may be less than 20%, requiring a comprehensive assessment based on age and ovarian reserve.
Risk Reminder: Success Rates and Expectation Management
No assisted reproductive technology can guarantee success on the first try. Data from public and private fertility centers in Hong Kong show that the single-cycle live birth rate varies significantly with age: about 40%-50% for under 35, 30%-35% for 35-39, 15%-20% for 40-42, and below 10% for over 43. These are population statistics and do not represent individual results.
When planning the next step, it is recommended to discuss the following three questions with your doctor:
- Based on current test results, what is the expected live birth rate approximately?
- Is the subsequent plan targeting the most likely cause of failure or a comprehensive investigation?
- If failures continue, what is the stopping threshold (i.e., after how many attempts should other paths be considered)?
Also note that some centers in Hong Kong may charge extra fees for complex cases, such as embryo culture fees, PGT biopsy fees, or embryo freezing fees. It is recommended to request a detailed fee schedule before starting the cycle to understand which items are charged per procedure and which per cycle, to avoid unexpected expenses midway.
Finally, if 2-3 consecutive cycles end with "no transferable embryo" or "all embryos chromosomally abnormal," seriously consider egg or embryo donation. This is not giving up but a rational choice based on medical facts.
✔ Female: AMH, thyroid function (TSH + TPOAb), Vitamin D, hysteroscopy (if indicated)
✔ Male: Sperm DNA fragmentation index, sperm morphology analysis
✔ Both: Chromosomal karyotype (if not yet done), infectious disease screening (valid for 6 months)
0 comments